Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer

  • Interventional
  • Recruiting
  • NCT05683691

Contact Information

  • Athanasios Liodos

Prospective, Multicenter, Single-Arm Study of VanquishTM Water Vapor Ablation for PrOstate CanceR

The purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate cancer.